Article metrics

Download PDFPDF

EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019440
Jan 2020881
Feb 2020660
Mar 202016161
Apr 202036363
May 202029296
Jun 202012120
Jul 202020205
Aug 202018181
Sep 202022220
Oct 202021216
Nov 202018182
Dec 202013135
Jan 202118186
Feb 202119197
Mar 2021252513
Apr 202115155
May 2021171714
Jun 2021171711
Jul 2021131310
Aug 2021111110
Sep 2021303016
Oct 2021151529
Nov 2021131321
Dec 2021303019
Jan 2022282910
Feb 2022181811
Mar 202229329
Apr 2022182214
May 2022171719
Jun 2022353511
Jul 202213146
Aug 2022212111
Sep 2022202212
Oct 2022272914
Nov 2022556
Dec 202220208
Jan 2023181810
Feb 202317198
Mar 2023222210
Apr 20238910
May 202321219
Jun 202320205
Jul 20239912
Aug 202311116
Sep 202319194
Oct 202317173
Nov 202311117
Dec 202315157
Jan 202417175
Feb 202420208
Mar 202413137
Apr 2024181815
May 202412129
Jun 2024151611
Jul 202417176
Aug 2024161615
Sep 2024141512
Oct 2024181814
Nov 2024262720
Dec 202435359
Jan 2025151511
Feb 2025121214
Mar 2025191913
Apr 2025232315
May 2025121310
Jun 2025232318
Total12101230625